Using methylprednisolone to prevent kidney injury during heart surgery
Official title: Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass: A Randomized Double-Blinded Clinical Study
Run by Ain Shams University · NCT06917859 · Data updated 2026-11-12
This study is testing if giving a single dose of methylprednisolone during heart surgery can help prevent kidney injury after the operation.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo, Abbasia) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | February 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | April 9, 2025 |
| Trial ID | NCT06917859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-65 scheduled for elective cardiac surgeries requiring cardiopulmonary bypass with an ASA score of III-IV.
✕Probably not a fit
Patients with a history of renal dysfunction, severe hepatic diseases, or those undergoing urgent surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of a single dose of methylprednisolone administered during cardiac surgeries that require cardiopulmonary bypass (CPB) in reducing the incidence of postoperative acute kidney injury (AKI). Patients will be randomly assigned to receive either methylprednisolone or a placebo after anesthesia induction and before CPB initiation. The primary outcome will be the occurrence of AKI within seven days post-surgery, assessed using the RIFLE criteria, while secondary outcomes will include hyperglycemia, ICU stay duration, hospital length of stay, and other postoperative complications.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of acute kidney injury in patients undergoing cardiac surgery, leading to better postoperative outcomes.
How similar studies have gone: While the use of corticosteroids in surgical settings has been explored, this specific prophylactic approach for renal protection during cardiac surgeries is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-65 years. 2. Sex: Both sexes. 3. Patients with American Society of Anesthesiologists (ASA) score III-IV. 4. Patients scheduled for any kind of elective cardiac surgical procedure requiring cardiopulmonary bypass (e.g., coronary artery bypass grafting (CABG), valve repair/replacement, or combined procedures ( Exclusion Criteria: 1. Declining to give written informed consent. 2. History of allergy to the medications used in the study. 3. Diabetic patients with HbA1C \>6.5 4. Moderate to severe hepatic diseases (Child B-C) 5. Hepatic dysfunction: INR \> 1.5, serum albumin \< 2.9 g%. 6. Renal dysfunction (serum Creatinine level \>1.3 mg/dl, or GFR \< 80 ml/min./1.73/m2 7. Patients with a recent history of AKI. 8. Patients undergoing urgent cardiac surgery. 9. Patients undergoing cardiac surgeries with deep hypothermic total circulatory arrest. 10. Planned off-pump procedure. 11. Any cardiac surgery exceeds 45 minutes on Aortic cross clamp. 12. Patients requiring high doses of inotropes and/or vasopressors intraoperative or postoperative (high-dose dopamine is defined as peak doses of \>15 μg/kg/min, high-dose norepinephrine is defined as peak dose \>0.1 μg/kg/min, high-dose epinephrine is defined as peak dose \>0.1 μg/kg/min) 13. Delayed extubation for more than 6 hours postoperative. 14. Patients developed postoperative complications as (septic shock and bleeding)
Where it's running
-
Ain Shams University
Cairo, Abbasia, Egypt Recruiting
Study contacts
- Study coordinator: Abdelrahman Atef Atef, M.B., B.Ch Faculty of Medicine
- Email: abdelrahman.atef@med.asu.edu.eg
- Phone: +201091541157
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
Integrated intraoperative hemodynamic monitoring during cardiac surgery with CPB
This pilot study tests a single-dashboard monitoring system to see if it can capture heart and tissue perfusion data during elective cardiac surgery with bypass in adults without changing patient care.
-
SP16 to help prevent kidney injury during cardiac surgery in people with CKD
Researchers are testing SP16 to see if it can prevent acute kidney injury in adults with chronic kidney disease who are having heart surgery that uses a heart-lung machine.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
Impact of cardiopulmonary bypass on platelet lipids and bleeding after cardiac surgery
This study tests how CPB changes platelet lipid metabolism and procoagulant platelets to see if these changes relate to inflammation and bleeding after cardiac surgery.
-
Transcutaneous auricular vagus nerve stimulation to prevent kidney injury after heart surgery
This trial tests whether applying a non-invasive ear stimulation (taVNS) around the time of elective heart surgery can help prevent acute kidney injury in adults undergoing cardiopulmonary bypass.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.